抗がん剤連日投与レジメンにおける制吐療法改定の悪心·嘔吐発現率と薬剤費に及ぼす効果
スポンサーリンク
概要
- 論文の詳細を見る
Nausea and vomiting are major adverse reactions in cancer chemotherapy and affect patients'quality of life.Though medical institutions have revised their antiemetic therapy guidelines,there have been few evaluations of the revisions especially for the continuous administration of anticancer drugs.We revised our guidelines for antiemetic therapy in the continuous administration of anticancer drugs and then investigated the effect on the incidence of nausea and vomiting and cost of antiemesis.Our subjects were 39 patients receiving high dose FP therapy (Day 1 : cisplatin 80mg/m2 ; Day 1-5 : 5-fluorouracil 800 mg/m2)for esophageal cancer at Kobe City Medical Center General Hospital.A conventional antiemetic therapy group (conventional group) received granisetron 3mg on Day 1 (20 patients),and a revised antiemetic therapy group (revised group) received granisetron 3mg plus dexamethasone (DEX) 20mg on Day 1 and DEX 4-12mg on Day 2-5 (19 patients).The incidences of nausea and vomiting in the conventional group were 80.0% and 30.0%,respectively and in the revised group 52.6% and 15.8%,respectively.There were significant decreases in the incidences of nausea and vomiting in the revised group as compared with the conventional group on Day 2,3 and 5 and Day 3,respectively.The occurrence of vomiting was 0.80±1.88 times in the conventional group and 0.21±0.54 times in the revised group.The cost of antiemesis for 1 course was 16,701±15,103 yen for the conventional group and 9,691±3,326 yen for the revised group.These results suggested that our revised antiemetic therapy for the continuous administration of anticancer drugs could reduce the incidence of nausea and vomiting as well as the cost of antiemesis in cancer chemotherapy.
- 日本医療薬学会の論文
日本医療薬学会 | 論文
- O17-003 視覚障害者に対する手技指導の標準化を目的とした視覚障害擬似体験インスリン注射院内実習(一般演題 口頭発表,糖尿病/後発医薬品,医療薬学の創る未来 科学と臨床の融合)
- 20H-16 Basal-Bolus療法におけるインスリンデテミルの有効性(使用状況調査・意識調査,来るべき時代への道を拓く)
- 30-P2-43 2種類のインスリン試薬を用いた化学発光酵素免疫測定法によってFactitious hypoglicemiaを証明しえた一例(副作用・有害事象,社会の期待に応える医療薬学を)
- 28-04-20 ペン型インスリン注射器の精度に及ぼす注入時抵抗とカートリッジ内気泡の影響
- P-610 ファブリー病に対する「ファブラザイム^[○!R]」投与時の「過敏反応発現時の対処方法」の一部改変により副作用防止に至った1症例(8.有害事象・副作用(基礎と臨床)1,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)